Cargando…

Propagation of Plasma L-Phenylalanine Concentration Fluctuations to the Neurovascular Unit in Phenylketonuria: An in silico Study

Phenylketonuria (PKU) is an inherited metabolic disease characterized by abnormally high concentrations of the essential amino acid L-phenylalanine (Phe) in blood plasma caused by reduced activity of phenylalanine hydroxylase (PAH). While numerous studies have shown association between high plasma P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taslimifar, Mehdi, Buoso, Stefano, Verrey, Francois, Kurtcuoglu, Vartan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454150/ https://www.ncbi.nlm.nih.gov/pubmed/31105574 http://dx.doi.org/10.3389/fphys.2019.00360

Ejemplares similares

Functional Polarity of Microvascular Brain Endothelial Cells Supported by Neurovascular Unit Computational Model of Large Neutral Amino Acid Homeostasis
por: Taslimifar, Mehdi, et al.
Publicado: (2018)

Analysis of L-leucine amino acid transporter species activity and gene expression by human blood brain barrier hCMEC/D3 model reveal potential LAT1, LAT4, B(0)AT2 and y(+)LAT1 functional cooperation
por: Taslimifar, Mehdi, et al.
Publicado: (2021)

Quantifying the relative contributions of different solute carriers to aggregate substrate transport
por: Taslimifar, Mehdi, et al.
Publicado: (2017)

The Bohr Effect Is Not a Likely Promoter of Renal Preglomerular Oxygen Shunting
por: Olgac, Ufuk, et al.
Publicado: (2016)

Mutations of the phenylalanine hydroxylase gene in Iranian patients with phenylketonuria
por: Biglari, Alireza, et al.
Publicado: (2015)

Age-Related Psychophysiological Vulnerability to Phenylalanine in Phenylketonuria
por: Leuzzi, Vincenzo, et al.
Publicado: (2014)

Therapeutic implication of L-phenylalanine aggregation mechanism and its modulation by D-phenylalanine in phenylketonuria
por: Singh, Virender, et al.
Publicado: (2014)

Blood phenylalanine instability strongly correlates with anxiety in phenylketonuria
por: Didycz, Bozena, et al.
Publicado: (2017)

Phenylalanine free infant formula in the dietary management of phenylketonuria
por: Yilmaz, Ozlem, et al.
Publicado: (2023)

Monitoring phenylalanine concentrations in the follow‐up of phenylketonuria patients: An inventory of pre‐analytical and analytical variation
por: Coene, Karlien L. M., et al.
Publicado: (2020)

Assessment of extracranial carotid artery disease using digital twins – A pilot study
por: Dubs, Linus, et al.
Publicado: (2023)

Mutations of the phenylalanine hydroxylase gene in patients with phenylketonuria in Shanxi, China
por: Zhou, Yong-An, et al.
Publicado: (2012)

Mutation analysis of Phenylalanine hydroxylase gene in Iranian patients with Phenylketonuria
por: Rastegar Moghadam, Mahsa, et al.
Publicado: (2018)

Comparison of phenylalanine tolerance in singleton and twin pregnancies in patients with phenylketonuria
por: Hozyasz, Kamil Konrad, et al.
Publicado: (2020)

Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice
por: Cacicedo, Maximiliano L., et al.
Publicado: (2022)

Aspartame and Phenylketonuria: an analysis of the daily phenylalanine intake of aspartame-containing drugs marketed in France
por: Maler, Victor, et al.
Publicado: (2023)

Neuroradiological findings of an adolescent with early treated phenylketonuria: is phenylalanine restriction enough?
por: Beckhauser, Mayara Thays, et al.
Publicado: (2011)

Phenylketonuria in the Latvian population: Molecular basis, phenylalanine levels, and patient compliance
por: Kreile, M., et al.
Publicado: (2020)

Diurnal variation of phenylalanine and tyrosine concentrations in adult patients with phenylketonuria: subcutaneous microdialysis is no adequate tool for the determination of amino acid concentrations
por: Grünert, Sarah C, et al.
Publicado: (2013)

Influence of Standard Laboratory Procedures on Measures of Erythrocyte Damage
por: Wiegmann, Lena, et al.
Publicado: (2017)

Clinical relevance of the discrepancy in phenylalanine concentrations analyzed using tandem mass spectrometry compared with ion-exchange chromatography in phenylketonuria
por: Stroup, Bridget M., et al.
Publicado: (2016)

Preparation of a Selective L-Phenylalanine Imprinted Polymer Implicated in Patients with Phenylketonuria
por: Najafizadeh, Parvaneh, et al.
Publicado: (2014)

Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria
por: Bell, Sean M., et al.
Publicado: (2017)

Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase
por: Tao, Rui, et al.
Publicado: (2020)

Improving phenylalanine and micronutrients status of children with phenylketonuria: a pilot randomized study
por: Zamani, Reza, et al.
Publicado: (2021)

Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase
por: Tao, Rui, et al.
Publicado: (2022)

Improved attention linked to sustained phenylalanine reduction in adults with early‐treated phenylketonuria
por: Bilder, Deborah A., et al.
Publicado: (2021)

Complications of the Low Phenylalanine Diet for Patients with Phenylketonuria and the Benefits of Increased Natural Protein
por: McWhorter, Nicole, et al.
Publicado: (2022)

Phenylalanine Tolerance over Time in Phenylketonuria: A Systematic Review and Meta-Analysis
por: Pinto, Alex, et al.
Publicado: (2023)

Vasculo-Neuronal Coupling and Neurovascular Coupling at the Neurovascular Unit: Impact of Hypertension
por: Presa, Jessica L., et al.
Publicado: (2020)

Blood phenylalanine fluctuation in phenylketonuric children treated by BH4 or low-phenylalanine diet from birth
por: Theron, Maurane, et al.
Publicado: (2023)

The spectrum of phenylalanine hydroxylase variants and genotype–phenotype correlation in phenylketonuria patients in Gansu, China
por: Zhang, Chuan, et al.
Publicado: (2023)

Lipid nanoparticle delivers phenylalanine ammonia lyase mRNA to the liver leading to catabolism and clearance of phenylalanine in a phenylketonuria mouse model
por: Diaz-Trelles, Ramon, et al.
Publicado: (2022)

Measurement of Neurovascular Coupling in Neonates
por: Hendrikx, Dries, et al.
Publicado: (2019)

Risk of Developing Insulin Resistance in Adult Subjects with Phenylketonuria: Machine Learning Model Reveals an Association with Phenylalanine Concentrations in Dried Blood Spots
por: Leal-Witt, María Jesús, et al.
Publicado: (2023)

Doxycycline hinders phenylalanine fibril assemblies revealing a potential novel therapeutic approach in phenylketonuria
por: De Luigi, Ada, et al.
Publicado: (2015)

The evaluation of phenylalanine levels in Estonian phenylketonuria patients during eight years by electronic laboratory records
por: Lilleväli, Hardo, et al.
Publicado: (2019)

The Impact of Phenylalanine Levels on Cognitive Outcomes in Adults With Phenylketonuria: Effects Across Tasks and Developmental Stages
por: Romani, Cristina, et al.
Publicado: (2017)

Effect of dietary regime on metabolic control in phenylketonuria: Is exact calculation of phenylalanine intake really necessary?
por: Rohde, Carmen, et al.
Publicado: (2015)

Intrinsic property of phenylalanine to trigger protein aggregation and hemolysis has a direct relevance to phenylketonuria
por: Anand, Bibin G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9d28jrugvdslu102vmjeeodecd